UBS Group AG

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1610520 ZURICH, V8

Back to TAK Full portfolio

Position in TAK

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$50,749,041

-$13,536,681 QoQ

Shares Held

2,740,229

-33.5% QoQ

Ownership

0.086%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 90.73792737760238.ToString("F0")% Shared 0.ToString("F0")% None 9.262072622397618.ToString("F0")%

Common Shares in TAK Over Time

Shares Held

Position Value (USD)

Derivatives in TAK

reported options exposure · as of Dec 31, 2021

CallValue

$10,632,763

CallShares

780,100

PutValue

$936,381

PutShares

68,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

UBS Group AG holds $1,524,520,292 across 81 Drug Manufacturers - Specialty & Generic names. TAK ranks #9 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	2,799,543	$330,933,975
2	ELAN	Elanco Animal Health Inc	8,572,057	$205,129,322
3	NBIX	Neurocrine Biosciences Inc	1,221,036	$160,859,281
4	UTHR	UNITED THERAPEUTICS Corp	236,729	$140,375,559
5	HIMS	Hims & Hers Health, Inc.	4,151,638	$86,188,003
6	INDV	Indivior Pharmaceuticals, Inc.	2,192,264	$66,820,205
7	LNTH	Lantheus Holdings, Inc.	867,675	$65,813,148
8	TEVA	Teva Pharmaceutical Industries Ltd	1,877,217	$56,541,775

All Filings in TAK

Export CSV

33 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$50,749,041	2,740,229	-33.5%	Shares	Defined	2026-05-05
2025-12-31	$64,285,722	4,123,523	-30.0%	Shares	Defined	2026-01-29
2025-09-30	$86,287,705	5,893,969	+46.4%	Shares	Defined	2025-11-13
2025-06-30	$62,221,025	4,024,646	+129.4%	Shares	Defined	2025-08-14
2025-03-31	$26,090,335	1,754,562	+5.6%	Shares	Defined	2025-05-13
2024-12-31	$22,000,007	1,661,632	+2175.7%	Shares	Defined	2025-02-14
2024-09-30	$1,038,272	73,015	-36.2%	Shares	Defined	2024-11-14
2024-06-30	$1,481,252	114,471	+19.0%	Shares	Defined	2024-08-14
2024-03-31	$1,336,591	96,227	+52.5%	Shares	Defined	2024-05-13
2023-12-31	$900,278	63,089	+22.8%	Shares	Defined	2024-02-09
2023-09-30	$794,924	51,385	-75.5%	Shares	Defined	2023-11-09
2023-06-30	$3,297,607	209,905	+154.5%	Shares	Defined	2023-08-11
2023-03-31	$1,359,039	82,466	-29.0%	Shares	Defined	2023-05-12
2022-12-31	$1,811,969	116,152	-6.3%	Shares	Defined	2023-02-08
2022-09-30	$1,608,330	124,004	+8.5%	Shares	Defined	2022-11-10
2022-06-30	$1,604,785	114,301	+7.4%	Shares	Defined	2022-08-10
2022-03-31	$1,523,647	106,400	-65.8%	Shares	Defined	2022-05-16
2021-12-31	$4,234,567	310,680	-60.2%	Shares	Defined	2022-02-14
2021-12-31	$10,632,763	780,100	+1035.5%	Call	Defined	2022-02-14
2021-12-31	$936,381	68,700	-1.4%	Put	Defined	2022-02-14
2021-09-30	$1,141,686	69,700	-74.3%	Put	Defined	2021-11-15
2021-09-30	$4,444,040	271,309	+178.3%	Shares	Defined	2021-11-15
2021-09-30	$1,597,050	97,500	+41.9%	Call	Defined	2021-11-15
2021-06-30	$1,156,221	68,700	-29.5%	Put	Defined	2021-08-13
2021-06-30	$1,640,925	97,500	-61.6%	Call	Defined	2021-08-13
2021-06-30	$4,276,788	254,117	-4.9%	Shares	Defined	2021-08-13
2021-03-31	$4,878,743	267,182	+288.9%	Shares	Defined	2021-05-12
2021-03-31	$1,254,462	68,700	-29.5%	Put	Defined	2021-05-12
2021-03-31	$1,780,350	97,500	-3.0%	Call	Defined	2021-05-12
2020-12-31	$1,829,518	100,523	+20.5%	Shares	Defined	2021-02-11
2020-09-30	$1,488,640	83,444	-4.0%	Shares	Defined	2020-11-12
2020-06-30	$1,558,941	86,946	+20.9%	Shares	Defined	2020-07-31
2020-03-31	$1,092,049	71,940	—	Shares	Defined	2020-05-01
No filing history on record for this holder in this stock.